DisclosureWe earn commission on partner links; ranking is set by our evidence-based methodology — not advertisers. Read policy

Photo: HealthVetted editorial render
GLP-1 receptor agonist

Photo: HealthVetted editorial render
GLP-1 receptor agonist
| # | Product | Active ingredient | Starting price | FDA status | Score | |
|---|---|---|---|---|---|---|
| 1 | Wisp OMG! Cream (Sildenafil Cream) | — | Best ·$11/mo | compounded | Top ·7.4 | See offer → |
| 2 | Ro Sparks | — | $48/mo | compounded | 7.3 | See offer → |
OMG! Cream delivers sildenafil, a PDE5 inhibitor, directly to clitoral tissue. The intent is to locally relax smooth muscle and increase blood flow, supporting engorgement, lubrication, and heightened sensitivity within minutes of application, while minimizing the systemic exposure you would get from a pill.
Sparks pairs two PDE5 inhibitors. Sildenafil acts quickly and tadalafil lasts much longer, so the combination is designed to deliver both a prompt and a sustained effect. Both work by preventing cyclic GMP breakdown in penile tissue, relaxing smooth muscle and boosting blood flow when you are aroused; neither creates desire on its own.
Sildenafil's vasodilatory mechanism is well established, and a topical application aims to harness that locally for arousal. However, evidence specifically supporting topical sildenafil for female sexual arousal disorder is limited and mixed, far less robust than the data for oral PDE5 inhibitors in men. Many users report subjective improvement in sensation, but this is a lightly studied, compounded use.
The individual ingredients, sildenafil and tadalafil, are among the most evidence-backed ED therapies, and combination PDE5 strategies are used clinically for men who under-respond to one agent. However, Sparks itself is a compounded finished product without its own FDA approval or large published trials, so its specific formulation is supported by the evidence for its components rather than by dedicated studies of the lozenge.
Because it is applied topically, systemic side effects are uncommon; the most likely issues are local irritation, tingling, warmth, or redness. The arginine-free formula is designed to avoid triggering herpes outbreaks. Stop use and consult a provider if irritation persists. This is educational information, not medical advice; individual results vary.
Because it combines two PDE5 inhibitors, dose-related effects like headache, flushing, indigestion, and muscle aches may be more noticeable than with a single low dose. Seek emergency care for an erection over four hours or sudden vision or hearing changes, and never combine with nitrates. Educational information only; individual results vary.
Subscriptions start around $11/month for a single bottle on a multi-month plan and roughly $20/month for two; one-time bottles are about $39 (one) or $66 (two). The consultation and prescription are folded into the cash price, and nothing is billed to insurance. Promotional first-order discounts are common.
Plans are billed monthly from about $48 (4 doses) to $120 (10 doses), with quarterly billing knocking roughly $15 off. That works out to about $11-$12 per dose, higher than generic tablets or many chewables. The provider visit and shipping are included, and it is cash-pay only.
Adults assigned female at birth seeking help with physical arousal, lubrication, or sensation, who complete Wisp's online intake and are cleared by a licensed provider. A clinician screens for contraindications; it is not intended to diagnose or treat low desire on its own.
Adults assigned male at birth with ED, cleared through Ro's online medical review, typically those seeking a stronger option after standard treatment. Not appropriate with nitrates or certain cardiovascular conditions; the provider determines suitability given the higher combined dose.
Ro Sparks: Ro Sparks is a sensible second-line option for men who tried a single ED pill and wanted more, but it is a compounded, premium-priced product rather than a first choice. Both are strong options — match the pick to your specific needs, budget, and clinician's guidance.
Editorial comparison, not medical advice. Discuss options with a qualified clinician. Individual results vary.